Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment

As an immune adjuvant, proinflammatory allogeneic dendritic cells (AlloDCs) have demonstrated promising immune-priming effects in several preclinical and clinical studies. The effector cells, including NK cells and T cells are widely acknowledged as pivotal factors in the effectiveness of cancer imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Arwa, Gao, Menghan, Iskantar, Alexandros, Wang, Hai, Karlsson-Parra, Alex, Yu, Di, Jin, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466132/
https://www.ncbi.nlm.nih.gov/pubmed/37654492
http://dx.doi.org/10.3389/fimmu.2023.1146413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466132/
https://www.ncbi.nlm.nih.gov/pubmed/37654492
http://dx.doi.org/10.3389/fimmu.2023.1146413

Ejemplares similares